Mico BioMed Co. Ltd. (214610) — Financial Flexibility Index
Mico BioMed Co. Ltd. (214610) has a Financial Flexibility Index of -1.03x as of September 2025. Free cash flow of ₩-8.13 Billion (operating CF ₩-8.13 Billion minus capex ₩0.00) represents -1% of total liabilities (₩7.88 Billion). Also explore 214610 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mico BioMed Co. Ltd. Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Mico BioMed Co. Ltd. across 9 annual periods. Check how strategically is Mico BioMed Co. Ltd.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Mico BioMed Co. Ltd. (2016–2024)
Year-by-year free cash flow to debt coverage for Mico BioMed Co. Ltd.. For the full company profile including market capitalisation, see Mico BioMed Co. Ltd. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.34x | ₩-9.71 Billion | ₩-10.70 Billion | ₩28.58 Billion | ▲ +20.5% |
| 2023 | -0.43x | ₩-10.68 Billion | ₩-11.36 Billion | ₩24.99 Billion | ▼ -37.4% |
| 2022 | -0.31x | ₩-12.38 Billion | ₩-14.01 Billion | ₩39.82 Billion | ▼ -96.6% |
| 2021 | -0.16x | ₩-5.76 Billion | ₩-8.60 Billion | ₩36.42 Billion | ▲ +81.6% |
| 2020 | -0.86x | ₩-12.92 Billion | ₩-18.68 Billion | ₩15.00 Billion | ▼ -127.4% |
| 2019 | -0.38x | ₩-9.10 Billion | ₩-10.43 Billion | ₩24.01 Billion | ▼ -41.7% |
| 2018 | -0.27x | ₩-4.93 Billion | ₩-6.79 Billion | ₩18.45 Billion | ▼ -43.0% |
| 2017 | -0.19x | ₩-2.43 Billion | ₩-2.89 Billion | ₩13.02 Billion | ▲ +72.1% |
| 2016 | -0.67x | ₩-3.79 Billion | ₩-3.99 Billion | ₩5.65 Billion | — |